Baidu
map

J Immunol:T胸腺中富集自身反应性B细胞

2016-06-09 佚名 生物谷

胸腺是T细胞分化的发生地,也是重要的淋巴器官。始祖T细胞从骨髓出来,经过皮质延髓束进入胸腺,并在其皮质区域进行TCR的重排。之后,表达TCR的这部分T细胞在胸腺中经历了两次重要的选择。首先,它们通过阳性选择检验了其表面的TCR与MHC的结合能力。其中,负责检验的是表面同时表达MHC-I与MHC-II的胸腺表皮细胞。之后,这部分通过了阳性选择的细胞再次经历阴性选择,这一步是为了检验T细胞与自身抗

胸腺是T细胞分化的发生地,也是重要的淋巴器官。始祖T细胞从骨髓出来,经过皮质延髓束进入胸腺,并在其皮质区域进行TCR的重排。之后,表达TCR的这部分T细胞在胸腺中经历了两次重要的选择。首先,它们通过阳性选择检验了其表面的TCR与MHC的结合能力。其中,负责检验的是表面同时表达MHC-I与MHC-II的胸腺表皮细胞。之后,这部分通过了阳性选择的细胞再次经历阴性选择,这一步是为了检验T细胞与自身抗原的结合能力。树突状细胞或胸腺表皮细胞表面的MHC分子会与自身抗原结合,并与T细胞相互作用。

胸腺表皮细胞表达的组织特异性自身抗原是由转录因子AIRE调控的,那些与自身抗原结合强度较高的T细胞将会诱发凋亡,从而保证免疫耐受的稳态。

虽然胸腺是T细胞分化的重要场所,但其中也存在大量的B淋巴细胞。它们在髓质区域聚集,并被T细胞所环绕。有研究表明这部分B细胞参与了自身抗原向T细胞的呈递。而且其表面表达MHC-II,能够有效呈递被BCR识别后的抗原物质。

B细胞主要在骨髓中分化完成,其中大部分B细胞都表达自身抗原特异性BCR。经过相似的选择过程,这部分细胞会被除去。最终离开骨髓进入循环系统的成熟B细胞中,20%存在自体反应性。

有研究表明,胸腺始祖细胞对于维持B细胞的潜能十分重要,也有文章指出胸腺中存在一定的B始祖细胞,而且这部分B细胞的BCR谱与骨髓来源的B细胞并不相同。

为了了解胸腺B细胞的细胞特性,来自荷兰鹿特丹医学中心大学的Menno C. van Zelm课题组进行了深入研究,相关结果发表在最近一期的《Journal of Immunology》杂志上。

首先,作者分离了小鼠胸腺的B细胞,并将其与骨髓来源的B细胞进行了比较。流式检测结果显示:小鼠胸腺中确实存在一定量的B细胞,而且这部分B细胞属于成熟但未激活的状态。

进一步,通过对B细胞内部BCR的重排过程进行分析,作者发现这部分细胞的BCR库与骨髓来源的B细胞并不相同。

之后,作者通过单细胞克隆技术分离了小鼠胸腺中以及骨髓中的B细胞,并将其与自身抗原进行反应。结果显示,胸腺中的B细胞大多具有自身抗原反应性。另外,作者发现这部分来自胸腺的B细胞具有多抗原反应性。

原始出处

Magdalena B. Rother, Marco W. J. Schreurs, Roel Kroek, Sophinus J. W. Bartol, Jacques J. M. van Dongen, and Menno C. van Zelm.The Human Thymus Is Enriched for Autoreactive B Cells.J immunol.2016

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2022779, encodeId=845f2022e79a4, content=<a href='/topic/show?id=188b3e7309c' target=_blank style='color:#2F92EE;'>#反应性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37730, encryptionId=188b3e7309c, topicName=反应性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Mon Jan 09 00:13:00 CST 2017, time=2017-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1663467, encodeId=e794166346e40, content=<a href='/topic/show?id=451a8418304' target=_blank style='color:#2F92EE;'>#胸腺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84183, encryptionId=451a8418304, topicName=胸腺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcbd25619530, createdName=1508842480_96220445, createdTime=Fri Nov 18 04:13:00 CST 2016, time=2016-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89373, encodeId=623a893e3d7, content=这个不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Sat Jun 11 08:21:00 CST 2016, time=2016-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89374, encodeId=de15893e4f4, content=需要学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Sat Jun 11 08:21:00 CST 2016, time=2016-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273168, encodeId=e76d12e3168f5, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3837, encryptionId=310d383ef5, topicName=B细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eba113, createdName=xiaoyeshuang, createdTime=Sat Jun 11 05:13:00 CST 2016, time=2016-06-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2022779, encodeId=845f2022e79a4, content=<a href='/topic/show?id=188b3e7309c' target=_blank style='color:#2F92EE;'>#反应性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37730, encryptionId=188b3e7309c, topicName=反应性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Mon Jan 09 00:13:00 CST 2017, time=2017-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1663467, encodeId=e794166346e40, content=<a href='/topic/show?id=451a8418304' target=_blank style='color:#2F92EE;'>#胸腺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84183, encryptionId=451a8418304, topicName=胸腺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcbd25619530, createdName=1508842480_96220445, createdTime=Fri Nov 18 04:13:00 CST 2016, time=2016-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89373, encodeId=623a893e3d7, content=这个不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Sat Jun 11 08:21:00 CST 2016, time=2016-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89374, encodeId=de15893e4f4, content=需要学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Sat Jun 11 08:21:00 CST 2016, time=2016-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273168, encodeId=e76d12e3168f5, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3837, encryptionId=310d383ef5, topicName=B细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eba113, createdName=xiaoyeshuang, createdTime=Sat Jun 11 05:13:00 CST 2016, time=2016-06-11, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2022779, encodeId=845f2022e79a4, content=<a href='/topic/show?id=188b3e7309c' target=_blank style='color:#2F92EE;'>#反应性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37730, encryptionId=188b3e7309c, topicName=反应性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Mon Jan 09 00:13:00 CST 2017, time=2017-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1663467, encodeId=e794166346e40, content=<a href='/topic/show?id=451a8418304' target=_blank style='color:#2F92EE;'>#胸腺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84183, encryptionId=451a8418304, topicName=胸腺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcbd25619530, createdName=1508842480_96220445, createdTime=Fri Nov 18 04:13:00 CST 2016, time=2016-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89373, encodeId=623a893e3d7, content=这个不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Sat Jun 11 08:21:00 CST 2016, time=2016-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89374, encodeId=de15893e4f4, content=需要学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Sat Jun 11 08:21:00 CST 2016, time=2016-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273168, encodeId=e76d12e3168f5, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3837, encryptionId=310d383ef5, topicName=B细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eba113, createdName=xiaoyeshuang, createdTime=Sat Jun 11 05:13:00 CST 2016, time=2016-06-11, status=1, ipAttribution=)]
    2016-06-11 milkshark

    这个不错

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2022779, encodeId=845f2022e79a4, content=<a href='/topic/show?id=188b3e7309c' target=_blank style='color:#2F92EE;'>#反应性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37730, encryptionId=188b3e7309c, topicName=反应性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Mon Jan 09 00:13:00 CST 2017, time=2017-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1663467, encodeId=e794166346e40, content=<a href='/topic/show?id=451a8418304' target=_blank style='color:#2F92EE;'>#胸腺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84183, encryptionId=451a8418304, topicName=胸腺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcbd25619530, createdName=1508842480_96220445, createdTime=Fri Nov 18 04:13:00 CST 2016, time=2016-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89373, encodeId=623a893e3d7, content=这个不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Sat Jun 11 08:21:00 CST 2016, time=2016-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89374, encodeId=de15893e4f4, content=需要学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Sat Jun 11 08:21:00 CST 2016, time=2016-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273168, encodeId=e76d12e3168f5, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3837, encryptionId=310d383ef5, topicName=B细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eba113, createdName=xiaoyeshuang, createdTime=Sat Jun 11 05:13:00 CST 2016, time=2016-06-11, status=1, ipAttribution=)]
    2016-06-11 milkshark

    需要学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2022779, encodeId=845f2022e79a4, content=<a href='/topic/show?id=188b3e7309c' target=_blank style='color:#2F92EE;'>#反应性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37730, encryptionId=188b3e7309c, topicName=反应性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Mon Jan 09 00:13:00 CST 2017, time=2017-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1663467, encodeId=e794166346e40, content=<a href='/topic/show?id=451a8418304' target=_blank style='color:#2F92EE;'>#胸腺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84183, encryptionId=451a8418304, topicName=胸腺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcbd25619530, createdName=1508842480_96220445, createdTime=Fri Nov 18 04:13:00 CST 2016, time=2016-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89373, encodeId=623a893e3d7, content=这个不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Sat Jun 11 08:21:00 CST 2016, time=2016-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89374, encodeId=de15893e4f4, content=需要学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Sat Jun 11 08:21:00 CST 2016, time=2016-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273168, encodeId=e76d12e3168f5, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3837, encryptionId=310d383ef5, topicName=B细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eba113, createdName=xiaoyeshuang, createdTime=Sat Jun 11 05:13:00 CST 2016, time=2016-06-11, status=1, ipAttribution=)]

相关资讯

研发混合益生菌或可低成本治疗肝癌

由香港大学生物系副教授Hani El-Nezami博士及Gianni Panagiotou博士领导的科研团队,与该校李嘉诚医学院及东芬兰大学医学系合作,研发出一种对肝癌具有潜在治疗效果的混合益生菌“Prohep”,有望成为治疗肝癌的一种低成本方案。

Lancet:脊髓灰质炎疫苗研究

研究者对拉丁美洲的婴儿进行了一项研究,评估接种双价口服脊髓灰质炎病毒疫苗类型1和3(bOPV)联合0、1或2剂量的灭活脊髓灰质炎病毒疫苗(IPV)后,婴儿的体液和肠道免疫情况。 该研究纳入了哥伦比亚、多米尼加共和国、危地马拉、巴拿马四个地区的6周足月婴儿,第一次接种疫苗时体检结果正常,没有急慢性病,随机分为9组,其中有5组的数据将在本报告中讨论,组1和组2(对照组)在第6、10、14周接种b

Nature:揭示抗体进入神经系统控制病毒感染机制

在一项新的研究中,来自美国耶鲁大学医学院的研究人员解决了免疫系统的一个谜团---抗体如何进入神经系统控制病毒感染。他们的发现可能对预防和治疗一系列疾病---包括与寨卡病毒相关联的格林-巴利综合征(Guillain-Barre Syndrome)---产生影响。

Nat Immunol:芳香烃受体负向调节抗病毒免疫反应

芳香烃受体(AHR,Aryl hydrocarbon receptor)是一类能够感受外界环境中的异质物(xenobiotic)刺激,并介导毒性反应的胞内转录调控因子。激活后的AHR能够调控许多染色体上基因的表达,并促进对异质物的分解。之前的研究发现该信号在细菌感染过程中发挥了十分重要的作用(细菌的特定毒性分子能够激活AHR并加速其代谢过程)。 AHR与免疫调节的关系也是一直以来研究的热点

Immunology:个体免疫力与疫苗的效率相关

最近,科学家们第一次证明了个体的差异与季节性流感疫苗的作用效率有一定的关系。该发现已经发表在免疫学顶级杂志《免疫学》(Immunology)上面了。大量的研究表明由于一系列类似于年龄因素的影响,流感疫苗的效价因人而异。 随着年龄的增加,人们的抵抗力逐渐下降。但是到目前为止,并没有一种方法可以让我们预测疫苗在不同人之间是否能够达到最佳的效果,这主要是因为人们在接种流感疫苗后会产生免疫反应从而获

SCRT:胎盘间充质干细胞治疗缺血性疾病又有新发现

近日,国家干细胞工程技术研究中心主任韩忠朝团队发表在Stem Cell Research & Therapy上的一篇题为《VCAM-1+胎盘绒毛膜间充质干细胞显示出强有力促血管生成活性》的文章受到国内外相关领域的高度关注。该文章阐述了血管细胞黏附分子-1+(VCAM-1+)胎盘绒毛膜间充质干细胞(CV-MSC)具有良好的促血管生成活性,成为理论走向临床治疗的重要一步。 许多研究已经证

Baidu
map
Baidu
map
Baidu
map